U.S. markets closed
  • S&P Futures

    3,810.25
    +16.25 (+0.43%)
     
  • Dow Futures

    30,427.00
    +117.00 (+0.39%)
     
  • Nasdaq Futures

    11,682.25
    +58.50 (+0.50%)
     
  • Russell 2000 Futures

    1,776.70
    +8.70 (+0.49%)
     
  • Crude Oil

    87.98
    +0.22 (+0.25%)
     
  • Gold

    1,729.50
    +8.70 (+0.51%)
     
  • Silver

    20.82
    +0.27 (+1.32%)
     
  • EUR/USD

    0.9909
    +0.0024 (+0.25%)
     
  • 10-Yr Bond

    3.7590
    +0.1420 (+3.93%)
     
  • Vix

    28.55
    -0.52 (-1.79%)
     
  • GBP/USD

    1.1353
    +0.0031 (+0.28%)
     
  • USD/JPY

    144.6880
    +0.0780 (+0.05%)
     
  • BTC-USD

    20,333.12
    +114.08 (+0.56%)
     
  • CMC Crypto 200

    461.98
    +3.57 (+0.78%)
     
  • FTSE 100

    7,052.62
    -33.84 (-0.48%)
     
  • Nikkei 225

    27,364.37
    +243.87 (+0.90%)
     

MedAvail to Present at the H.C. Wainwright 24th Annual Global Investment Conference

·1 min read

MISSISSAUGA, Ontario & PHOENIX, Ariz., August 30, 2022--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) ("MedAvail") a technology-enabled retail pharmacy company, today announced that the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference in New York.

MedAvail’s management is scheduled to present on Tuesday, September 13, 2022, at 2:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company’s website at https://investors.medavail.com.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220830005260/en/

Contacts

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com